Note of caution15 Jul 2020 21:33
Remember to take your profits guys. Wish you all well here, but there are red flags which need to be considered. I know biotech is inherently risky anyway, but remember the top guys got Synergy de-listed from Nasdaq. Maybe the circumstances and products were different, but I also recall reading that products they sold to Bristol Myers Squibb ending up being written off. The last two sets of accounts have required sternly worded cautionary notes from the auditors (I think the 2018 accounts had to be re-stated because of irregularities) and shareholders are now having to agree to a huge capital loss for the latest accounts. The cash position is precarious and funding runs out at the end of July state-side. Don't wish anyone ill here, just have your eyes wide open and make sure you crystallise profits whilst you can.